文献速递骨质疏松与钙磷/甲状旁腺

较低血清硬骨素水平与动脉僵硬度增加风险升高相关:JPOS队列研究

Association of Lower Serum Sclerostin Levels With Elevated Risk for Increased Arterial Stiffness: The JPOS Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在日本人群骨质疏松研究(JPOS)中,对556名社区居住的50岁以上女性进行平均4.0年随访,发现血清硬骨素水平较低三分位者动脉僵硬度增加风险升高,低三分位校正后OR为2.50(P=.014),提示较低血清硬骨素水平与动脉僵硬度增加风险升高相关。

要点

  • 在556名日本社区女性中,平均随访4.0年,94人出现动脉僵硬度增加。
  • 低、中、高三分位动脉僵硬度增加率分别为22.2%、16.1%、12.4%(趋势检验P=.013)。
  • 充分校正后,低三分位较高三分位动脉僵硬度增加风险升高,OR为2.50(P=.014)。

核心结论

  • 较低血清硬骨素水平与日本社区居住女性动脉僵硬度增加风险升高相关。

研究设计与样本

  • 日本人群骨质疏松研究(JPOS)纵向队列,纳入556名基线baPWV<1800 cm/s的50岁以上社区居住女性,随访4至5年。

主要发现

  • 平均随访4.0年期间,94名女性出现动脉僵硬度增加。
  • 低、中、高三分位动脉僵硬度增加率分别为22.2%、16.1%、12.4%(趋势检验P=.013)。
  • 仅校正年龄和基线baPWV后,中三分位OR为1.58(P=.205),低三分位OR为2.16(P=.027)。
  • 进一步校正BMI、高血压、高脂血症、糖尿病、eGFR及全身骨矿物质含量后,中三分位OR为1.65(P=.181),低三分位OR为2.50(P=.014)。

关键数值与推荐

  • baPWV≥1800 cm/s定义为动脉僵硬度增加的切点。
  • 硬骨素测定变异系数为3.45%。
  • 以高三分位为参照,校正年龄和基线baPWV后低三分位OR为2.16(P=.027),中三分位OR为1.58(P=.205)。
  • 充分校正后低三分位OR为2.50(P=.014),中三分位OR为1.65(P=.181)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Studies on the relationship between serum sclerostin, a Wnt/β-catenin pathway inhibitor, and atherosclerosis have yielded inconsistent results. OBJECTIVE: We aim to longitudinally investigate the relationship between serum sclerostin levels and the risk of increased arterial stiffness in Japanese community-dwelling women from the Japanese Population-based Osteoporosis Study (JPOS). METHODS: Of 1044 women aged ≥ 50 years whose brachial-ankle pulse wave velocity (baPWV) value was available in a baseline survey in 2011-2012, we excluded 374 whose baPWV values were ≥ 1800 cm/s, set as the cutoff for increased arterial stiffness, and 8 with missing data. Of the remaining 662 women, 556 participated in the 4- to 5-year follow-up study and were included in the analysis. The coefficient of variation of the sclerostin measurement was 3.45%. We obtained odds ratios (ORs) for sclerostin at baseline, categorized by tertiles, with the high tertile as reference for increased arterial stiffness. RESULTS: Increased arterial stiffness occurred in 94 women during a mean follow-up of 4.0 years. The increased arterial stiffness rates in the low, medium, and high tertiles were 22.2%, 16.1%, and 12.4%, respectively (trend test P = .013). The ORs for the medium and low tertiles for increased arterial stiffness were 1.58 (P = .205) and 2.16 (P = .027), respectively, after adjusting for age and baseline baPWV. After further adjustment for baseline body mass index, hypertension, hyperlipidemia, diabetes mellitus, estimated glomerular filtration rate, and whole-body bone mineral content, the ORs for the medium and low tertiles were 1.65 (P = .181) and 2.50 (P = .014), respectively. CONCLUSION: Lower serum sclerostin levels were associated with elevated risks for increased arterial stiffness in Japanese community-dwelling women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tamaki J, Tachiki T, Jaalkhorol M, et al. Association of Lower Serum Sclerostin Levels With Elevated Risk for Increased Arterial Stiffness: The JPOS Cohort Study. J Clin Endocrinol Metab. 2025. PMID: 39530177. doi:10.1210/clinem/dgae795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。